Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells.
about
Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cellsAltered expression of insulin receptor isoforms in breast cancerPhase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors.Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signalingAnticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell CancerDisruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cellsImpact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation.Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.Type I insulin-like growth factor receptor signaling in hematological malignancies.Cellular functions regulated by phosphorylation of EGFR on Tyr845.Insulin receptor isoforms: an integrated view focused on gestational diabetes mellitus.Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance.
P2860
Q28539177-97EE616B-2770-4769-A749-6FBD3C745ED8Q28743464-C21ADFB4-B251-431A-B875-24802313C177Q33275887-A22D21DF-B3F2-4D89-AE48-782B341C39E1Q34382797-4092B0EB-9386-4D49-8867-265C00BF3D61Q34654408-ABC22160-D885-48C6-BDAC-D4F5CDA70BAAQ35050195-1B793F28-5F13-4265-8B8E-4B69213A0C25Q35683561-50183423-BE0C-4112-A52D-35E3799ECF55Q35875753-F11A66C5-3FF4-4C00-BC5F-7E1055AA9403Q37171068-6A0A2B49-08F9-41E6-A5C1-D7A8CA3E8C1EQ37337898-A985F161-C991-46FA-9532-3BA0D3AB30CFQ37386140-4FDD6703-38D8-4E01-95EF-1F3C62114F52Q37397276-5DC1F116-B1DF-45BE-9F8D-FF1DCC1212D4Q37702186-BBB6C994-5124-47D4-B11E-139F9F80337CQ38109021-D6E00628-5A2D-4B64-ADD0-BFE60A0F7229Q38597801-7D24BD27-BF50-403A-A8EB-AC23B025F9B6Q42579657-B5C6E524-78A4-4067-8BC6-08A072A8869E
P2860
Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of insulin receptor ...... resistant colon cancer cells.
@en
type
label
Inhibition of insulin receptor ...... resistant colon cancer cells.
@en
prefLabel
Inhibition of insulin receptor ...... resistant colon cancer cells.
@en
P2093
P2860
P356
P1476
Inhibition of insulin receptor ...... o resistant colon cancer cells
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603237
P407
P50
P577
2006-07-04T00:00:00Z